Utah Law Banning Inappropriate Material In School Libraries Faces Legal Challenge
The Traffic Tickets Looked Routine. The Pattern Behind Them Didn’t.
Jasmine Crockett Might Be Getting Nervous After This Poll
Here's How Republicans Feel About Trump's Greenland Plan
Here's How Much Money CA Is Losing As Hollywood Takes Production to Friendlier...
FBI Serves Subpoenas to Offices of Minnesota Gov. Tim Walz, AG Keith Ellison,...
After Losing Government Immigration Money, Catholic Bishops Question America’s ‘Moral Role...
Hijab Solidarity? No, Thank You.
Exclusive: Bombshell Footage Claims Judges Can Be Bought With Bribes in Ohio Immigration...
Flashback: Here's What Don Lemon Once Said About the Kidnapping and Torture of...
Trump Dumps ATF Merger Plan
Guess How Much of Every Humanitarian Dollar the US Spends Actually Reaches the...
You Won't Believe These Deleted Posts by Mamdani's Equity Chief
President Trump Trolls Europe With These AI-Generated Images
Keith Ellison Defends Church Storming As 'Free Speech' After ICE Protest Shuts Down...
Tipsheet

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’

AP Photo/Pablo Martinez Monsivais, File

Speaking during remarks to a J.P. Morgan healthcare conference this week, Pfizer CEO Albert Bourla openly stated current vaccines the company developed for Wuhan coronavirus offer "limited, if any" protection against contracting current variants of the disease. He then encouraged booster shots. 

The statement from Bourla comes as the Biden administration continues to justify vaccine mandates for federal workers, contractors and private businesses. The Supreme Court heard arguments about President Biden's mandates for private companies and medical workers last week. A ruling is expected soon on the constitutionality of the mandates. 

A number of people who have pointed out the waning efficacy of Pfizer's vaccines, which Bourla touted last year as being "100 percent" effective against contracting or transmitting the virus, have been banned by social media companies. 

Meanwhile, Bourla also announced this week the company is developing a vaccine specific to Omicron. It is expected to be ready in March when health officials predict the latest wave of the mild variant will already be over. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos